Cell-Free DNA Isolation & Extraction Market by Consumable, Platform, Technique, Application, End-User

Description

List of Tables

[194 Pages Report] The Cell-Free DNA Isolation & Extraction Market size was estimated at USD 1.96 billion in 2023 and expected to reach USD 2.14 billion in 2024, at a CAGR 5.57% to reach USD 2.87 billion by 2030.

Global Cell-Free DNA Isolation & Extraction Market

KEY MARKET STATISTICS
Base Year [2023]	USD 1.96 billion
Estimated Year [2024]	USD 2.14 billion
Forecast Year [2030]	USD 2.87 billion
CAGR (%)	5.57%

Cell-Free DNA Isolation & Extraction Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell-Free DNA Isolation & Extraction Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell-Free DNA Isolation & Extraction Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell-Free DNA Isolation & Extraction Market, highlighting leading vendors and their innovative profiles. These include Abbexa Ltd, Abnova Corporation, Agilent Technologies, Inc., Alpha Laboratories Ltd, AMSBIO LLC, BioChain Institute Inc., Covaris, LLC, DH Life Sciences, LLC., EntroGen Inc, EpiGentek Group Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, NeoGeneStar LLC, Nonacus Limited, Norgen Biotek Corporation, NVIGEN, Inc., Omega Bio-tek, Inc., PerkinElmer, Inc., Promega Corporation., Streck LLC, System Biosciences, LLC, Takara Bio Inc. by Takara Holdings Inc, Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and Vela Diagnostics by Luye Medical Group Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Cell-Free DNA Isolation & Extraction Market to forecast the revenues and analyze trends in each of the following sub-markets:

Consumable
- Kits
- Tubes
Platform
- Next-Generation Sequencing
- Polymerase Chain Reaction
Technique
- Magnetic Beads-Based
- Spin Column-Based
Application
- Non-Invasive Prenatal Testing
- Oncology
- Transplant Rejection
End-User
- Academic Research Institutes & Laboratories
- Clinical Diagnostic Centers
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell-Free DNA Isolation & Extraction Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell-Free DNA Isolation & Extraction Market?

3. What are the technology trends and regulatory frameworks in the Cell-Free DNA Isolation & Extraction Market?

4. What is the market share of the leading vendors in the Cell-Free DNA Isolation & Extraction Market?

5. Which modes and strategic moves are suitable for entering the Cell-Free DNA Isolation & Extraction Market?

Product Code: MRR-7C31448F0BBD

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cell-Free DNA Isolation & Extraction Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising requirement of cellular samples for studying genetic and cellular diseases
  - 5.1.1.2. Utilization of cell-free DNA as a biomarker in cancer detection
  - 5.1.1.3. Inclination towards non-invasive methods of disease diagnosis and prediction
- 5.1.2. Restraints
  - 5.1.2.1. High cost of bioinstrumentation needed for DNA extraction and lack of skilled personnel
- 5.1.3. Opportunities
  - 5.1.3.1. Adoption of cell free DNA for development of personalized medicine and therapies
  - 5.1.3.2. Development of novel strategies for extraction and quantification of DNA
- 5.1.4. Challenges
  - 5.1.4.1. Complex regulations concerning sample collection and storage
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cell-Free DNA Isolation & Extraction Market, by Consumable

6.1. Introduction
6.2. Kits
6.3. Tubes

7. Cell-Free DNA Isolation & Extraction Market, by Platform

7.1. Introduction
7.2. Next-Generation Sequencing
7.3. Polymerase Chain Reaction

8. Cell-Free DNA Isolation & Extraction Market, by Technique

8.1. Introduction
8.2. Magnetic Beads-Based
8.3. Spin Column-Based

9. Cell-Free DNA Isolation & Extraction Market, by Application

9.1. Introduction
9.2. Non-Invasive Prenatal Testing
9.3. Oncology
9.4. Transplant Rejection

10. Cell-Free DNA Isolation & Extraction Market, by End-User

10.1. Introduction
10.2. Academic Research Institutes & Laboratories
10.3. Clinical Diagnostic Centers
10.4. Contract Research Organizations
10.5. Pharmaceutical & Biotechnology Companies

11. Americas Cell-Free DNA Isolation & Extraction Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cell-Free DNA Isolation & Extraction Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Cell-Free DNA Isolation & Extraction Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
- 15.1.1. Abbexa Ltd
- 15.1.2. Abnova Corporation
- 15.1.3. Agilent Technologies, Inc.
- 15.1.4. Alpha Laboratories Ltd
- 15.1.5. AMSBIO LLC
- 15.1.6. BioChain Institute Inc.
- 15.1.7. Covaris, LLC
- 15.1.8. DH Life Sciences, LLC.
- 15.1.9. EntroGen Inc
- 15.1.10. EpiGentek Group Inc.
- 15.1.11. F. Hoffmann-La Roche Ltd
- 15.1.12. Illumina, Inc.
- 15.1.13. Merck KGaA
- 15.1.14. NeoGeneStar LLC
- 15.1.15. Nonacus Limited
- 15.1.16. Norgen Biotek Corporation
- 15.1.17. NVIGEN, Inc.
- 15.1.18. Omega Bio-tek, Inc.
- 15.1.19. PerkinElmer, Inc.
- 15.1.20. Promega Corporation.
- 15.1.21. Streck LLC
- 15.1.22. System Biosciences, LLC
- 15.1.23. Takara Bio Inc. by Takara Holdings Inc
- 15.1.24. Thermo Fisher Scientific Inc.
- 15.1.25. TransGen Biotech Co., Ltd.
- 15.1.26. Vela Diagnostics by Luye Medical Group Co., Ltd
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing